ABT stock: buy or sell?
February 21st, 2020
Should I buy ABT stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Abbott Laboratories stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Abbott Laboratories stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for ABT stock for the last 30 days.
ABT stock analysis
Abbott Laboratories ended on February 21st at $87.45 and depreciated an unpleasant -1.14%.
Abbott Laboratories shares depreciated -1.14% to $87.45 on Feb 21st. On October ABT price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On December, SMA50d and SMA100d crossed up triggering a rise of 1.03%. On Jan 22nd, ABT hit a new all time high, pushing higher than on January 21st tops. Check different trading setups that use ATHs as triggers.
Abbott Laboratories shares dropped -2.46% this week, ending at $87.45.
ABT shows a long term strength with several rising tops and rising bottoms. It left a new bottom at $86.75 early February. Previous top ($92.45) will play as a resistance in possible new gains. Not so far away is the last price record Abbott Laboratories marked late January. By mid December 2019, SMA10w and SMA20w crossed up triggering a rise of 1.71%. Since late November 2019 when ABT stock price broke up the SMA20w line, it gained $4.06 (4.87%).
ABT stock price history
ABT stock went public on March 17th, 1980 with a price of $0.001. Since then, ABT stock grew a inf%, with a yearly average of inf%. If you had invested $1,000 in ABT stock in 1980, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
ABT stock historical price chart
ABT stock reached all-time highs on Jan 22nd with a price of $92.45.
ABT stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' ABT stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price forecast for Abbott Laboratories stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on April, Abbott Laboratories . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a cool increase of 11.64% to $30,578.00 million dollars. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) escalated a 6.00% to 7.74%. Abbott Laboratories fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Abbott Laboratories TTM sales up to March 2019 were $30,723.00 and earnings $2,622.00 million USD. If we compare this TTM figures with the last reported annuality, we can esteem Abbott Laboratories business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, remained steady a tight 0.47%. Similarly, profit margin (net income/revenues) stayed constant at 7.74%.
|2013||$19,660 M||-||$1,970 M10.0%||-|
|2014||$20,247 M||2.99%||$2,284 M11.3%||15.94%|
|2015||$20,405 M||0.78%||$4,423 M21.7%||93.65%|
|2016||$20,853 M||2.20%||$1,400 M6.7%||-68.35%|
|2017||$27,390 M||31.35%||$477 M1.7%||-65.93%|
|2018||$30,578 M||11.64%||$2,368 M7.7%||396.44%|
|TTM||$30,723 M||0.47%||$2,622 M8.5%||10.73%|
Quarterly financial resultsAbbott Laboratories posted $7,535.00 million in sales for 2019-Q1, a -2.96% decline compared to previous quarter. Reported quarter income marked $672.00 M with a profit margin of 8.92%. Profit margin remained steady a 0.50% compared to previous quarter when profit margin was 8.42%. When comparing sales to same quarter last year, Abbott Laboratories sales marked a slightly good growth and appreciated a 1.96%.
|2017-Q2||$6,640 M||-||$269 M4.1%||-|
|2017-Q3||$6,830 M||2.86%||$558 M8.2%||107.43%|
|2017-Q4||$7,589 M||11.11%||$-828 M-10.9%||-248.39%|
|2018-Q1||$7,390 M||-2.62%||$418 M5.7%||-150.48%|
|2018-Q2||$7,767 M||5.10%||$733 M9.4%||75.36%|
|2018-Q3||$7,656 M||-1.43%||$563 M7.4%||-23.19%|
|2018-Q4||$7,765 M||1.42%||$654 M8.4%||16.16%|
|2019-Q1||$7,535 M||-2.96%||$672 M8.9%||2.75%|
Abbott Laboratories ownershipWhen you are planning to buy shares of a company, it's always worth to check its ownership structure.
Abbott Laboratories shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.70% of all shares.
In case of Abbott Laboratories stock, 76.53% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ABT stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$154.8 B|
|Total shares||1,770.0 M|
|Float shares||1,760.0 M|
|- Institutional holdings (%)||76.5%|
|- Insider holdings (%)||0.7%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$87.16 - $88.25|
|Average true range||$1.37|
|50d mov avg||$87.55|
|100d mov avg||$85.02|
|200d mov avg||$83.55|
Abbott Laboratories performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. For Abbott Laboratories, the benchmark is made against .
Abbott Laboratories competitorsUnfortunately, we could not find any public company that could be defined as Abbott Laboratories competitor. This doesn't mean Abbott Laboratories does not have any competitor in the market, it's just we could not detected it.
Latest ABT stock news
- InvestorPlaceAbbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 BeatJuly 17, 2019
- Seeking AlphaAbbott Laboratories: A Solid Business For An Attractive ValuationMay 8, 2019
- InvestorPlaceAbbott Laboratories Earnings: ABT Stock Down After Q1 BeatApril 17, 2019
- InvestorPlaceAll Signals Are Positive for Buying Abbott LaboratoriesJanuary 22, 2019
- InvestorPlace3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott LaboratoriesJanuary 4, 2019